Normosang, Konzentrat zur Herstellung einer Infusionslösung

7680527760156 CH-52776 Konzentrat
Normosang, Konzentrat zur Herstellung einer Infusionslösung
Normosang, Konzentrat zur Herstellung einer Infusionslösung
Normosang, Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
4 x 10
Selling units
4
Measure
ml
Galenic form
Konzentrat
Galenic group
Tinkturen/Desinfektion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
08/10/2025
Summary of Product Characteristics
Français
08/10/2025
Summary of Product Characteristics
Italien
08/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.0 G Substance HBESI
(N/A)
940.0 MG Substance HBESI
(N/A)
4.0 G Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

RECORDATI AG

4057 Basel

Authorization information

Swissmedic authorization number
52776
Drug name
Normosang, Konzentrat zur Herstellung einer Infusionslösung
Galenic form
KOINF
ATC Code
B06AB01
Authorization status
Z
Dispensing category
A
First authorization
09/02/1995
Authorization expiration date
31/12/9999
IT Number
06.99.0.
Domain
Human medicine
Field of application
akute hepatische Porphyrie

Package details

Description (FR)
NORMOSANG conc perf 250 mg/10ml 4 amp 10 ml
Description (DE)
NORMOSANG Inf Konz 250 mg/10ml 4 Amp 10 ml
Market launch
09/02/1995
Narcotic (BTM)
No

Application methods

IV